Clovis Oncology reported $-55979000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -26415000 7.15M
Agenus AGEN:US USD -56715000 7.48M
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Anika Therapeutics ANIK:US USD -1912000 1.37M
Arrowhead Research ARWR:US USD -72046000 116.41M
AstraZeneca AZN:LN USD 3.09B 52M
Clovis Oncology CLVS:US USD -55979000 15.39M
Enanta Pharmaceuticals ENTA:US USD -26334000 5.81M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
GlaxoSmithKline GSK:LN GBP 2.43B 602M
Halozyme Therapeutics HALO:US USD 73.71M 21.78M
Heron Therapeutics HRTX:US USD -41882000 14.48M
Insmed INSM:US USD -130773000 35.63M
Intrexon XON:US USD -7694000 18.45M
Mirati Therapeutics MRTX:US USD -173307000 3.14M
Neurocrine Biosciences NBIX:US USD 97.9M 121.2M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 10.67B 3.11B
Rigel Pharmaceuticals RIGL:US USD -19037000 5.54M
Sangamo Biosciences SGMO:US USD -53125000 10.03M
Ultragenyx Pharmaceutical RARE:US USD -238819000 80.96M
Veracyte VCYT:US USD -8875000 772K
YTE INCY:US USD 178.22M 131.36M